Arthur Kuan's most recent trade in Cg Oncology Inc. was a trade of 64,612 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on March 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cg Oncology Inc | Arthur Kuan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.72 per share. | 12 Mar 2026 | 64,612 | 200,763 | - | 1.7 | 111,133 | Common Stock |
| Cg Oncology Inc | Arthur Kuan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 64,612 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Cg Oncology Inc | Arthur Kuan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.15 per share. | 12 Mar 2026 | 1,847 | 198,916 | - | 60.1 | 111,097 | Common Stock |
| Cg Oncology Inc | Arthur Kuan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.72 per share. | 04 Mar 2026 | 102,871 | 139,022 | - | 1.7 | 176,938 | Common Stock |
| Cg Oncology Inc | Arthur Kuan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 102,871 | 64,612 | - | - | Employee Stock Option (Right to Buy) | |
| Cg Oncology Inc | Arthur Kuan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.61 per share. | 04 Mar 2026 | 2,871 | 136,151 | - | 61.6 | 176,882 | Common Stock |
| Cg Oncology Inc | Arthur Kuan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 527,660 | 527,660 | - | - | Employee Stock Option (Right to Buy) | |
| Cg Oncology Inc | Arthur Kuan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 397,800 | 397,800 | - | - | Stock Option (Right to Buy) |